In a filing, Zimmer Biomet Holdings Inc revealed its Group President, Asia Pacific Yi Sang unloaded Company’s shares for reported $95000.0 on Jun 11 ’25. In the deal valued at $95.00 per share,1,000 shares were sold. As a result of this transaction, Yi Sang now holds 20,424 shares worth roughly $1.88 million.
Then, Yi Sang bought 800 shares, generating $74,011 in total proceeds.
Before that, Yi Sang bought 1,000 shares. Zimmer Biomet Holdings Inc shares valued at $95,000 were divested by the Officer at a price of $95.00 per share.
JP Morgan upgraded its Zimmer Biomet Holdings Inc [ZBH] rating to an Overweight from a a Neutral in a research note published on December 17, 2024; the price target was increased to $128 from $125. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in early September with a ‘”a Peer perform”‘ rating. Piper Sandler also remained covering ZBH and has decreased its forecast on July 01, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. Goldman started covering the stock on May 30, 2024. It rated ZBH as “a Neutral”.
Price Performance Review of ZBH
On Monday, Zimmer Biomet Holdings Inc [NYSE:ZBH] saw its stock jump 0.96% to $92.16. Over the last five days, the stock has lost -0.72%. Zimmer Biomet Holdings Inc shares have fallen nearly -12.75% since the year began. Nevertheless, the stocks have fallen -14.23% over the past one year. While a 52-week high of $116.71 was reached on 04/03/25, a 52-week low of $89.22 was recorded on 06/03/25.
Levels Of Support And Resistance For ZBH Stock
The 24-hour chart illustrates a support level at 90.89, which if violated will result in even more drops to 89.62. On the upside, there is a resistance level at 92.90. A further resistance level may holdings at 93.64.
